2024 Annual Meeting | C164 - Clinical EMG 1: Nerve Conduction Studies and Needle EMG: Patterns in Neuromuscular Disorders

Date Wednesday 04/17/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | Four Seasons 2/3

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kelly G. Gwathmey, MD

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should understand the basic concepts underlying nerve conduction studies including pitfalls and technical factors appreciate common nerve conduction patterns in neuromuscular disorders; apply needle EMG for the diagnosis of neuromuscular disorders. This program complements Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography, but covers independent topics.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM MDT	Introduction	Introduction Kelly G. Gwathmey, MD
01:05 PM - 01:35 PM MDT	Speaker	Approach to Nerve Conduction Studies Kelly G. Gwathmey, MD
01:35 PM - 02:10 PM MDT	Speaker	Nerve Conduction Studies: Clinical Patterns in Neuromuscular Disorders Ruple S. Laughlin, MD, FAAN
02:10 PM - 02:45 PM MDT	Speaker	Needle EMG: Clinical Patterns in Neuromuscular Disorders Aaron E. Izenberg, MD
02:45 PM - 03:00 PM MDT	Q&A	Questions & Answers Kelly G. Gwathmey, MD, Ruple S. Laughlin, MD, FAAN, Aaron E. Izenberg, MD

Faculty Disclosures
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Aaron E. Izenberg, MD	Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexxion. Dr. Izenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alnylam.